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Abstract  
The preparation of smart Ln:ZrO2@SiO2 nanoplatforms with grafted photosensitizer (Rose 
Bengal) which couple optical imaging with photo-dynamic therapy (PDT) is presented. A 
careful control of the lanthanide dopant loading is considered to enhance the photoemission 
properties of the lanthanide ions (Er, Pr, Yb) inside the ZrO2 crystal structure. The nanosystem 
with the lowest lanthanide loading maintains the size, phase and morphology of pristine ZrO2 
nanoparticles and exhibit the best performances in term of the overall luminescence properties. 
Upon functionalization with a silica shell to covalently bound Rose Bengal, a theranostic 
platform is prepared which is very efficient in singlet oxygen generation, as demonstrated by 
EPR and UV-Vis spectroscopy studies. Preliminary cell viability tests show that while both 
pristine and Ln doped ZrO2 nanoparticles do not exert cytotoxicity, neither upon illumination 
nor in dark condition, Rose Bengal grafted samples are able to significantly reduce cell viability 












In recent years there has been a continuous growth in the design and engineering of 
multifunctional nanomaterials to be used in medicine as theranostic platforms. Luminescent 
lanthanide (Ln3+)-doped inorganic nanoparticles (LNPs) are emerging as a new class of 
bioprobes and as an alternative to conventional molecular probes such as lanthanide chelates 
and organic dyes.[1-3] LNPs have attracted growing attention for their potential applications in 
different areas such as biodetection, bioimaging, and theranostics, owing to their superior 
physicochemical features such as long luminescence (from several to tens of milliseconds) 
lifetime, narrow emission bands, high chemical stability, high resistance to photobleaching, and 
low toxicity.[4-7] Compared to fluoride NPs (NaYF4 and NaGdF4), that have received great 
attention due to their upconversion properties,[8] Ln-doped inorganic oxide NPs are considered 
highly promising as a new and huge family of luminescent bioprobes for their photostability 
and chemical and thermal stability due to their more rigid crystalline environment and higher 
lattice binding energy. Beside biocompatible inorganic oxides, zirconium oxide (ZrO2) is 
considered an excellent material for optical applications due to its wide bandgap, good 
transparency, high refractive index and low phonon energy (470 cm-1) and can be an ideal host 
for Ln3+ ions to achieve long-lived Ln luminescence.[9,10] The presence of Ln3+ ions into the 
ZrO2 matrix allows to modulate the emission properties towards the “first biological window” 
(650-950 nm) [11] and more interesting towards the “second biological window” (1000-1500 
nm). In this latter NIR range, the light offers deeper penetration, reduced optical scattering [12] 
with respect to both the first biological window and the visible region, and diminished auto-
fluorescence. Beside the emission features in a suitable NIR region, it is important to couple 
other functionalities in order to have therapeutic agents and to develop an efficient theranostic 
nano-platforms. To introduce an additional chemical functionality, it is necessary to change the 
hydrophobicity of LNPs surface. Among various methods, the growth of a silica shell on LNPs 




can be easily modified to introduce various functional groups (−COOH, −NH2, −SH, etc.) via 
silanization, which can satisfy various needs of conjugating biological molecules or functional 
nanoparticles.[13,14] A smart design of LNP@SiO2 nanoplatforms with different kinds of 
functionalities will enable the development of multifunctional nanomedical platforms coupling 
biosensing, multimodal bioimaging, drug delivery or photo-dynamic therapy (PDT).[15]  
Herein we report the development of luminescent lanthanide-doped core shell (LNP@SiO2) 
nanoparticles functionalized with Rose Bengal (RB), a type II photosensitizer (PS), to couple 
optical imaging with PDT. The different steps of the synthetic procedures and the physico-
chemical properties of the LNP@SiO2RB have been deeply investigated to evidence the 
emission properties in the Vis-NIR range due to lanthanide ions together with the PDT 
efficiency of RB. Er, Yb and Pr(III) ions have been inserted separately, with different loadings, 
in the ZrO2 nanoparticles. A careful control of the rare earth ions loadings into the ZrO2 network 
is extremely important due to the possible ZrO2 structure modification inferred by the doping 
ions insertion; for this reason, different lanthanide ions loadings have been explored. To 
covalently attach the RB, LNPs have been modified with a silica shell containing amino-groups 
that are necessary to bind covalently RB. Among the large variety of organic dyes, halogen-
xanthene dyes, such as Rose Bengal, are well known as PS due to their intense absorption bands 
in the green region of the visible spectrum (480–550 nm) and high yield in the generation of 
singlet oxygen. In particular, RB is notable for its high triplet quantum yield (FT = 0.76), fairly 
long lived triplet state (t1/2 = 0.1–0.3 ms), and high singlet oxygen quantum yield (F 1O2 = 0.75 
under 540 nm light irradiation).[16-18] The RB loading has been chosen considering some 
previous studies in order to avoid RB aggregation. [19,20] The singlet oxygen release ability of 
the RB grafted samples was evaluated by indirect scavenger-assisted UV-Vis and EPR 
methods. Furthermore, preliminary cell viability tests were carried out in order to test the 
potential cytotoxicity of lanthanide doped ZrO2 nanoparticles as such and after 




2. Results and Discussion 
 
2.1. Characterization of lanthanide-doped ZrO2 nanoparticles  
Zirconium dioxide nanoparticles doped with different rare-earth ions (Ln:ZrO2) were 
successfully prepared by following a simple hydrothermal procedure that uses Zr oxychloride 
and lanthanide nitrates as precursors. Er3+, Pr3+ and Yb3+ ions were chosen as dopants and three 
doping-loadings were investigated for each Ln:ZrO2 system. In Table 1, acronyms, sample 
composition and loading of dopant ions of the synthesized nanoparticles are reported. The 
actual loading of lanthanide dopants was checked by EDX (Energy Dispersive X-ray) analysis, 
confirming that the desired stoichiometry was achieved (see table S1 and figure S1).   
 
Table 1 Acronyms and lanthanide loading of the doped ZrO2 nanoparticles  
Sample composition Acronyms 
Lanthanide loading * 
1%                 2%              10% 
Er:ZrO2 EZ1 EZ2 EZ10 
Pr:ZrO2 PZ1 PZ2 PZ10 
Yb:ZrO2 YZ1 YZ2 YZ10 
* dopant concentration is expressed as: [Ln/(Ln+Zr)]x100 
 
In order to investigate the effect of the lanthanide ion incorporation on the phase composition 
of the ZrO2 matrix, XRD patterns were acquired for the pure and the doped ZrO2 samples 
(Figure 1). To determine the crystallite size and the relative abundance of phases, Rietveld 
refinement was performed on the experimental patterns using the MAUD software [21]; the 
results, reported in table S2, allowed us to assign the present phases to tetragonal and 
monoclinic.[22] The diffraction pattern of the pure ZrO2 matrix (curve a) obtained with this 
synthetic method is therefore a mixture of monoclinic (m-ZrO2, reflections labelled with full 
circles in figure 1) and tetragonal (t-ZrO2, reflections labelled with full triangles in figure 1) 




is favoured with respect to the monoclinic one and the highest loading samples (10%, curves d) 







Figure 1 XRD patterns of (a) pure ZrO2 and Ln-doped ZrO2, where Ln= Er (section A), Pr (section B) 
or Yb (section C), at increasing dopant concentrations: (b) 1%; (c) 2% and (d) 10%. Reflections 
typical of m-ZrO2 and t-ZrO2 are labelled with full circles and full triangles respectively and reference 
patterns of monoclinic and tetragonal ZrO2 are reported. 
 
 
The width of the diffracted peaks assigned to the m-ZrO2 is not constant with the angle of 
diffraction for all samples, indicating a certain anisotropy in the crystallite dimensions,[23] as 
confirmed by the values of maximum (D) and minimum (d) crystallite sizes obtained from the 
Rietveld refinement along the [110] and [-111] plans, respectively (table S2 and figure S2).  
Hence, the m-ZrO2 crystallites cannot be considered as “nanospheres” but are more likely 
characterized by an elliptic shape, as confirmed by TEM imaging (Figure S3, supplementary 
information). Both pure ZrO2 and Ln:ZrO2 samples are mainly constituted of anisotropic 
monoclinic phase crystallites (ca. 50x20 nm); furthermore, some smaller particles, typical of 
tetragonal phase, are also present. 
The pristine nanoparticles are well dispersed in ethanol (Table S3, supplementary 
information) as evidenced by Dynamic Light Scattering (DLS) measurements. 
The effect of the lanthanide ion concentration on the optical properties of the ZrO2 
nanoparticles was investigated by Diffuse reflectance (DR) UV-Vis-NIR spectroscopy (Figure 
2). All spectra are dominated in the UV region by ZrO2 band-gap transition at 250 nm that is 
not significantly affected by the presence of lanthanide dopants. The weak absorption around 






Figure 2 DR UV-Vis spectra of pure ZrO2 (black curve) and Ln-doped ZrO2, where Ln= Er (panel A), 
Pr (panel B) or Yb (panel C), at increasing dopant concentrations: 1% (red curve); 2% (blue curve) and 
10% (green curve) 
 
In the visible region, the intensity of the complex set of absorption bands typical of the 
lanthanides f-f transitions, increases along with the dopant loading. The presence of these 




preserve their electronic properties, even in the samples at the highest loading. The positions 
and the corresponding f-f transitions of Er, Pr and Yb ions are reported in Table 2. [24,25] 
 
Table 2  Assignment of the Er3+, Pr3+ and Yb3+ transitions observed in DR UV-Vis-NIR spectra 
Ln3+ ion λabs [nm] f-f transitions 
Er3+ 
356 4I15/2 à 2G7/2 
365 4I15/2 à 2K15/2 + 4I15/2 à 4G9/2 
377 4I15/2 à 4G11/2 
407 4I15/2 à2H9/2 
440 4I15/2 à4F3/2 
450 4I15/2 à4F5/2 
488 4I15/2 à4F7/2 
520 4I15/2 à2H11/2 
545 4I15/2 à 4S3/2 
654 4I15/2 à 4F9/2 
788 4I15/2 à4I5/2 
966 4I15/2 à 4I11/2 
Pr3+ 
280 3H4à1S0 
450 3H4à 3P2 
475 3H4à 3P1 + 3H4à 1I6 
487 3H4à 3P0 





The visible and NIR emission spectra of all the samples are reported in Figure 3 and the 
positions and the corresponding f-f emissions of Er, Pr and Yb ions are reported in Table 3. In 
order to select the more efficient excitation wavelength, emission spectra were measured upon 
excitation at the different absorption maxima identified from the DR UV-Vis spectra. For all 
samples, a rapid decrease in luminescence intensity occurs along with the increase dopant 
loading, due to the concentration quenching effects. [26,27] Pr3+ ions excited from the ground state 
3H4 to the 3P2 level, relax non-radiatively to the metastable 3P0 state. The 1D2 state can be 
populated due to cross-relaxation or multiphonon non-radiative relaxation from 3P0 while the 
3P1 state is thermally populated. As a consequence, emission from all these levels are possible, 






Figure 3 Visible and NIR emission spectra A, A’ Er:ZrO2 samples; B, B’ PrZrO2 samples; C: Yb:ZrO2 
samples at increasing dopant concentrations: 1% (red curves); 2% (blue curves) and 10% (green curves)  
 
 
The five peaks in NIR emission spectra of Yb:ZrO2 are associated to the transitions from the 
lowest sublevel of excited multiplet 2F5/2 to the sublevels of ground multiplet 2F7/2.[29] In 
particular, the most intense signals centred at 977 nm and 1005 nm are assigned to the transition 






Table 3 Assignment of the emission of Er3+, Pr3+ and Yb3+ transitions observed in fluorescence 
spectra 
Ln3+ ion λexc [nm] 
λem 





660-670 4F9/2à 4I15/2 
653 1400-1600 4I13/2à4I15/2 
Pr3+ 450 




1115 1D2à 3F3 + 1D2à 3F4 
Yb3+ 912 930-1200 2F5/2à2F7/2 
 
In order to use Ln:ZrO2 as contrast agent for optical imaging, the results obtained with the 
luminescence spectroscopy has allowed the selection of the lowest-doping lanthanide samples 
EZ1, PZ1 and YZ1 for the subsequent functionalization to introduce the therapeutic agent. The 
low loading of lanthanide dopant, in fact, ensures the maintenance of the size, phase and 
morphology of pristine ZrO2 nanoparticles and leads to the best performances in term of the 
overall luminescence properties. 
 
2.2. Functionalization of EZ1, PZ1 and YZ1  
A surface modification of Ln:ZrO2 nanoparticles is necessary to introduce an additional 
chemical functionality. The deposition of a non-porous silica shell with amino groups onto EZ1, 
PZ1 and YZ1 nanoparticles (EZ1@SiO2, PZ1@SiO2 and YZ1@SiO2) has been chosen as a 
simple method to introduce surface functionality (-NH2 groups) to covalently bound a 










Scheme 1 Functionalization of the Ln:ZrO2 nanoparticles through the deposition of an aminopropyl-
functionalized silica shell and subsequent covalent immobilization of Rose Bengal. 
 
The presence of the silica shell was confirmed by Transmission Electron Microscopy (TEM) 
and the surface features of the silica-coated nanoparticles before and after the photosensitizer 
anchoring were assessed by FTIR spectroscopy analysis. In Figure 4 representative TEM 
images of the silica coated EZ1 nanoparticles and the corresponding FTIR spectra, collected 
before and after the anchoring of the photosensitizer, are reported.  EZ1 particles appeared to 
be uniformly coated by a ca. 20-25 nm thick silica shell (figure 4A); neither uncoated ZrO2 






Figure 4 A. Representative TEM image of silica coated EZ1@SiO2 sample; B. FTIR spectra of silica 
coated EZ1@SiO2 sample before (black curve) and after (pink curve) the anchoring of Rose Bengal 
(EZ1@SiO2RB). 
 
The FTIR spectrum on the silica coated sample, recorded after outgassing the sample at room 
temperature for 1 hour (Figure 4B, black curve), is characterized by signals at 2967, 2930 and 
2870 cm-1, ascribed to stretching modes of the CH2 groups of the aminopropyl chain and CH3 
groups of not completely hydrolysed alkoxy groups. The presence of free amino groups is 
confirmed by the signals at 3370 and 3300 cm-1, due to the symmetric and asymmetric 
stretching of NH2 groups; the corresponding bending mode is visible at 1595 cm-1.  
Rose Bengal (RB) was covalently anchored to free amino groups exposed on the surface of 
EZ1@SiO2, PZ1@SiO2 and YZ1@SiO2. The anchoring of RB to amino groups was confirmed 
by the presence of the band at 1380-1390 cm-1 due to the C-N stretching mode of amide II [30] 
and the bands at 1660 and 1593 cm-1 due to the C=O stretching and N-H bending modes, 
respectively, in the FTIR spectrum reported in Figure 4B (pink curve).  
Visible and NIR emission spectra of Ln@SiO2 and Ln@SiO2RB samples are reported in 
Figure 5. In the Vis emission spectra of EZ1@SiO2 (Figure 5A), the typical bands of Er3+ can 
be found at 415 nm, 525 nm, 548 nm, 560 nm, 660 nm and 675 nm. In the case of the 
EZ1@SiO2RB sample, the signals are partially covered by the emission band of RB, which is 




emission spectrum of RB is not significantly perturbed after the anchoring onto EZ1@SiO2; in 
fact, the position and maximum-to-shoulder intensity ratio of the emission spectrum of 
EZ1@SiO2RB are very close to those of the spectrum of diluted RB solution. This is an 
indication of the uniform distribution of RB on the silica surface, with a low degree of 
aggregation. As expected, NIR emission spectra (Figure 5A’) are not perturbed neither by the 
deposition of the silica shell nor by the anchoring of the PS, which has no emission in the NIR 
region of the spectrum.  
 
Figure 5 Visible and NIR emission spectra of A, A’ Er:ZrO2 samples; B, B’ PrZrO2 samples; C: 





In Figure 5 B and B’ visible and NIR emission spectra of PZ1@SiO2 and PZ1@SiO2RB are 
reported. Also in this case, the visible emission spectrum of PZ1@SiO2RB is dominated by the 
intense absorption band of RB, whilst the NIR emission spectra appeared to be unperturbed by 
the deposition of the silica shell and the subsequent anchoring of the photosensitizer. Finally, 
in Figure 5C the NIR emission spectra of functionalized YZ1 samples are reported; no influence 
of the silica shell deposition or of the anchoring of RB on the photoemission properties were 
detected. 
 
2.3. Evaluation of Singlet Oxygen production  
A comparative evaluation of the 1O2 release ability of the three nanoplatforms was carried 
out by an indirect chemical method, using 1,3-diphenylisobenzofuran (DPBF) as scavenger 
molecule.[31] DPBF, in fact, rapidly reacts with 1O2 forming the colourless o-dibenzoylbenzene 
derivative. The 1O2 scavenger activity can be monitored through a decrease in the electronic 
absorption band of DPBF at 411 nm upon illumination for increasing time at 520 nm (Figure 
6). Irradiation of the pristine lanthanide doped ZrO2 nanoparticles and of the correspondent 
silica coated samples (Figure S4, supplementary information) does not cause an alteration in 
the DPBF band, as expected, whilst all the three RB-functionalized samples possess very high 





Figure 6 Decrease of the absorption band at 411 nm of DPBF as a function of the irradiation time in 
presence of EZ1@SiO2-RB, PZ1@SiO2-RB and YZ1@SiO2-RB. 
The production of singlet oxygen was also evaluated by the spin trapping technique, 
using 2,2,6,6-Tetramethyl-4-piperidone (TEMP) as spin trap; the latter reacts with 1O2 released 
in solution to form the stable nitroxide radical 4-oxo-TEMPO radical adduct, which has a 
typical EPR signal. All the experiments performed in dark condition did not led to the formation 
of any detectable radical species. When the experiment was performed under irradiation only 
the samples containing RB led to the formation of the 4-oxo-TEMPO radical. For all samples 
the maximum signal intensity was achieved after 60 minutes of irradiation. To evaluate the 
singlet oxygen production, a double integration of the spectra was performed, since the 
integrated intensities of the EPR signal are proportional to the number of spins (radicals). The 





Figure 7 Integrated intensities of the EPR signal as a function of time 
 
2.4. Preliminary cell test  
In order to test the potential cytotoxicity of lanthanide doped ZrO2 nanoparticles as such 
and after functionalization, the effects of increasing EZ01 or EZ01@SiO2-RB concentrations 
(0-500 µg/mL) on HeLa cells viability were explored by using the Crystal Violet (CV) assays. 
No toxicity was observed up to a dose higher than 500 µg/mL (data not shown). Moreover, as 
the RB-functionalized samples released singlet oxygen upon irradiation, the same samples were 
tested in vitro for their photodynamic activity. Briefly, HeLa cells were treated for 4h in absence 
of foetal bovine serum (FBS) with 25µg or 50µg of EZ01 or EZ01@SiO2-RB, followed by 
illumination for 5 or 10 minutes and 20h of recovery in presence of FBS. As expected, no 
significant effect on cell viability was exerted by EZ01, neither illuminated nor in dark 
conditions. Interestingly, both EZ01@SiO2-RB concentrations were able to significantly reduce 
cell viability under light exposure, with respect to control condition (CTRL) and not illuminated 









Figure 8 Cell viability after A 4h treatment in absence of FBS with 25µg of EZ01 or EZ01@SiO2RB, 
followed by illumination for 10 minute, and 20h of recovery in presence of FBS (**p<0.01, *p<0.05); 
B 4h treatment in absence of FBS with 50µg of EZ01 or EZ01@SiO2RB, followed by illumination for 
5 minute, and 20h of recovery in presence of FBS (**p<0.05, *p<0.1); C 4h treatment in absence of 
FBS with 50µg of EZ01 or EZ01@SiO2RB, followed by illumination for 10 minute, and 20h of recovery 











Smart Ln:ZrO2@SiO2 nanoplatforms with grafted photosensitizer (Rose Bengal) have been 
developed to couple optical imaging with photo-dynamic therapy (PDT). A careful control of 
the lanthanide dopant loading was considered to enhance the photoemission properties of the 
lanthanide ions (Er, Pr, Yb) inside the ZrO2 crystal structure. 
Among all the samples synthesized, the nanosystems with lowest Ln loading have evidenced 
high emission intensities in the Vis and NIR region. In addition, upon subsequent 
functionalization with a silica shell to covalently bound Rose Bengal, a theranostic platform 
has been obtained and the efficiency in the delivery of singlet oxygen, the cytotoxic agent, have 
been proved by spin trapping EPR and UV-Vis spectroscopies. Preliminary cell viability tests 
have evidenced that both pristine and Ln doped ZrO2 nanoparticles are not cytotoxic, neither 
upon illumination nor in dark condition. On the contrary, Rose Bengal grafted samples are able 
to significantly reduce cell viability under light exposure, thus confirming the high potential of 
these nanoparticles as PDT tools.   
 
4. Experimental Section  
Materials. All the reagents and solvents were purchased by Sigma Aldrich (Milano, 
Italy) and used as received unless otherwise specified. 
Synthesis of lanthanide-doped ZrO2 nanoparticles (Ln:ZrO2). The samples were 
prepared via a hydrothermal process starting from a 1.0 M aqueous solution containing the 
stoichiometric ratio of ZrOCl2·8H2O and the Ln precursor (Er(NO3)3·5H2O; Pr(NO3)3·6H2O; 
Yb(NO3)3·5H2O). The pH was then adjusted to 11 using a 4.0 M NaOH aqueous solution, 
inducing the formation of a gel. The gel was then transferred into a 125 mL Teflon-lined 
stainless-steel acid digestor, 70% filled, which was heated in oven at 448 K overnight. The 
precipitates were then centrifuged and washed several times, then dried at 333 K. For 
comparison pure ZrO2 was prepared with the same procedure. For each Ln dopant, samples of 




Deposition of non-porous silica shell onto lanthanide-doped ZrO2 nanoparticles 
(Ln:ZrO2@SiO2). The deposition of a non-porous silica layer onto the lanthanide-doped ZrO2 
nanoparticles was performed according to literature procedures.[32] 0.5 g of Ln:ZrO2 were first 
suspended in 250 ml of a 1:4 distilled water:absolute ethanol mixture, then 2.5 ml of ammonium 
hydroxide solution (28-30%) were added to the suspension, following by the dropwise addition 
of 500μl of Tetraethylorthosilicate (TEOS) as the main silicon source and 50 μl of 
aminopropyltriethoxysilane (APTES) as the source of functional groups for the covalent 
conjugation of the photosensitizer. The reaction mixture was stirred at room temperature for 6 
hours. The solid product was recovered by centrifugation (10 minutes at 8000 rpm) and washed 
twice with distilled water.  
Covalent conjugation of Rose Bengal (RB) on the surface of Ln:ZrO2@SiO2. 0.3 g of the 
Ln:ZrO2@SiO2 material were first suspended in 50 ml of distilled water, then 100 μl of a 3M 
solution of RB in dimethylformamide (DMF) were added along with 100 μl of a 0.12M solution 
of N-(3-Dimethylaminopropyl)-N′-ethyl carbodiimide hydrochloride (EDAC) in distilled 
water. The reaction mixture was stirred at room temperature in the dark for 4 hours, then the 
solid product was recovered by centrifugation and washed twice with distilled water. 
 Characterization. XRD patterns were obtained using an ARL XTRA48 diffractometer with 
Cu Kα radiation (λ = 1.54062 Ǻ). Energy dispersive X-ray (EDX) spectroscopy analysis were 
carried out on a FEG-SEM TESCAN S9000G instrument equipped with Oxford microanalysis 
detector Ultim Max and AZTEC Software. Transmission Electron Microscopy (TEM) images 
were collected on a JEOL 3010 High Resolution Transmission Electron Microscope operating 
at 300 kV. Specimens were prepared by dispersing the sample by sonication in isopropanol and 
by depositing a few drops of the suspension on carbon-coated grids. Dynamic Light Scattering 
(DLS) experiments were performed at 25°C on aqueous MSNs dispersions using Malvern 
Zetasizer Nano-ZS Instrument, which uses a 4mW He-Ne laser operating at 633 nm and a 




measured immediately after ultrasonication for 15 minutes. Hydrodynamic diameters were 
obtained from the Intensity-weighted size distribution curve.  FTIR spectra of self-supporting 
pellets were collected under vacuum conditions (residual pressure <10-5 Torr) using a Bruker 
Equinox 55 spectrometer equipped with a pyroelectric detector (DTGS type) with a resolution 
of 4 cm-1. UV-Vis absorption spectra and DR UV-Vis-NIR spectra were recorded using a Perkin 
Elmer Lambda 900 spectrometer equipped with a diffuse reflectance sphere attachment. 
Photoemission and excitation steady state spectra were acquired with a Horiba Scientific 
Fluorolog spectrofluorimeter equipped with a 450 W Xenon lamp and two detectors: a 
Hamamatsu R928 photomultiplier for the measurements in the visible range of the spectrum 
and a LN cooled InGaAs photodiode for measurements in the NIR region. The spectral response 
was corrected for the spectral sensitivity of the detector.  
Determination of Singlet Oxygen generation. 1,3-diphenylisobenzofuran (DPBF) was used 
as scavenger molecule to evaluate singlet oxygen generation, in fact DPBF rapidly reacts with 
1O2 forming the colourless o-dibenzoylbenzene derivative. The 1O2 scavenger activity can be 
monitored through a decrease in the electronic absorption band of DBPF at 411 nm. A solution 
of DPBF (20 μM) was added to suspensions of the RB-functionalized samples in water and the 
final suspension was irradiated with a light source at 520 nm (450 W Xenon Lamp). After fixed 
time intervals, absorption spectra were collected on a Perkin Elmer Lambda 900 instrument. 
The decrease DBPF absorption contribution at 411 nm was plotted as a function of the 
irradiation time. The production of singlet oxygen was also evaluated by the spin trapping 
technique, using 2,2,6,6-Tetramethyl-4-piperidone (TEMP) as spin probe. The spin probe reacts 
with the 1O2 to form the stable nitroxide radical 4-oxo-TEMPO, which has a fingerprint ESR 
signal. 20mg of powder were suspended with 1000μL of MilliQ water. Then, 250μL of a 0.15M 
TEMP solution were added. The suspension was irradiated with a 500W Xe lamp (Oriel 




experiments were repeated in dark, without irradiation. Spectra of 50μL of suspension were 
monitored at 0, 5, 10, 15, 30 and 60 minutes of irradiation. 
Cell Culture. HeLa cells, a cervical cancer cell line, were grown at 37°C, 5% CO2, in DMEM 
supplemented [33] with 10% foetal bovine serum (FBS) and 1% antibiotic mixture. 
Crystal Violet (CV) assay. Cell viability was assessed by staining cells with the CV dye. Cells 
were settled overnight (20000 cells/well) and then incubated with increasing concentration of 
EZ01 or EZ01@SiO2RB (range 0-500 µg/mL) for 4h in absence of FBS. After 20h of recovery 
in presence of FBS, the medium was then removed, cells were gently washed once with PBS, 
stained for 10 min with 0.5% CV in 145 mmol/L NaCl, 0.5% formal saline, 50% ethanol, and 
washed thrice with water. CV was eluted from cells with 33% acetic acid. Plates were read at 
540 nm in a plate reader (Infinite 200 Pro, Tecan).[33] Successively cells were treated for 4h in 
absence of FBS with 25µg or 50µg of EZ01 or EZ01@SiO2RB, followed by illumination for 5 
or 10 minutes. After 20h of recovery in presence of FBS cell viability was assessed by staining 
with the CV dye as previous described. 
Statistical analysis. Data were analyzed with the Instat software package (GraphPad 
Software) by 1way ANOVA followed by Bonferroni post-test. 
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